- Home
- RELX vs MDT Comparison
RELX vs MDT Comparison
Compare RELX & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELX
- MDT
- Stock Information
- Founded
- RELX 1903
- MDT 1949
- Country
- RELX United Kingdom
- MDT Ireland
- Employees
- RELX N/A
- MDT N/A
- Industry
- RELX Business Services
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RELX Consumer Discretionary
- MDT Health Care
- Exchange
- RELX Nasdaq
- MDT Nasdaq
- Market Cap
- RELX 97.3B
- MDT 114.9B
- IPO Year
- RELX N/A
- MDT N/A
- Fundamental
- Price
- RELX $47.95
- MDT $92.51
- Analyst Decision
- RELX Strong Buy
- MDT Buy
- Analyst Count
- RELX 2
- MDT 17
- Target Price
- RELX N/A
- MDT $98.33
- AVG Volume (30 Days)
- RELX 1.4M
- MDT 6.4M
- Earning Date
- RELX 08-26-2025
- MDT 08-19-2025
- Dividend Yield
- RELX 1.82%
- MDT 3.09%
- EPS Growth
- RELX 3.29
- MDT 30.80
- EPS
- RELX 1.42
- MDT 3.61
- Revenue
- RELX $13,062,063,298.00
- MDT $33,537,000,000.00
- Revenue This Year
- RELX $6.66
- MDT $6.33
- Revenue Next Year
- RELX $6.63
- MDT $5.26
- P/E Ratio
- RELX $33.67
- MDT $25.48
- Revenue Growth
- RELX 2.48
- MDT 3.62
- 52 Week Low
- RELX $44.19
- MDT $79.29
- 52 Week High
- RELX $56.33
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- RELX 24.99
- MDT 60.37
- Support Level
- RELX $47.45
- MDT $91.45
- Resistance Level
- RELX $47.90
- MDT $93.16
- Average True Range (ATR)
- RELX 0.46
- MDT 1.32
- MACD
- RELX -0.33
- MDT 0.04
- Stochastic Oscillator
- RELX 2.49
- MDT 89.66
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.